Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-09-30

FDA Approved: DESIPRAMINE HYDROCHLORIDE — Supplemental Application (Ingenus Pharmaceuticals, LLC)

View source ↗

Summary

The FDA approved a Supplemental Application for Desipramine hydrochloride from Ingenus Pharmaceuticals, LLC, confirming continued market availability of the gen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DESIPRAMINE HYDROCHLORIDE (Desipramine hydrochloride)

Snippet

SUPPL AP for DESIPRAMINE HYDROCHLORIDE (DESIPRAMINE HYDROCHLORIDE)